文献速递神经肿瘤

巨大无功能垂体腺瘤限制有效安全切除的固有肿瘤特征

Inherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas.
PubMed 文献 · World Neurosurg · 2017-07-19

本文回顾128例连续手术的巨大无功能垂体腺瘤(>40 mm)患者,分析术前肿瘤特征、手术入路、结局与组织学。93例(72.7%)实现全切除或除外海绵窦的次全切除;肿瘤较大(P=0.0107)、大量颅内延伸(P=0.0352)和不规则形态(P=0.0016)与切除程度较低相关。永久性手术并发症28例(22.0%),作者认为大量颅内延伸、不规则形态和明显海绵窦侵犯是独立限制有效切除的固有因素。

要点

  • 128例巨大无功能垂体腺瘤(>40 mm)中,93例(72.7%)实现全切除或除外海绵窦的次全切除。
  • 肿瘤较大(P=0.0107)、大量颅内延伸(P=0.0352)和不规则形态(P=0.0016)与除外明显海绵窦侵犯后的切除程度较低相关。
  • 永久性手术并发症发生于28例(22.0%);作者认为上述固有因素独立限制有效切除,高危肿瘤需个体化治疗策略。

核心结论

  • 无论手术入路如何,大量颅内延伸、不规则形态和明显海绵窦侵犯是独立限制有效切除的固有因素。
  • 这些高危肿瘤需要个体化的治疗策略。

研究设计与样本

  • 回顾128例连续手术的巨大无功能垂体腺瘤(>40 mm)患者的术前肿瘤特征、手术入路、结局和组织学。
  • 随访期19至113个月(平均62.2个月)。

主要发现

  • 109例采用经蝶入路,19例采用经蝶联合经颅入路。
  • 93例(72.7%)实现全切除或除外海绵窦的次全切除。
  • 除外明显海绵窦侵犯后,肿瘤较大(P=0.0107)、大量颅内延伸(P=0.0352)和不规则形态(P=0.0016)与切除程度较低相关。
  • 永久性手术并发症发生于28例(22.0%)。
  • 所有患者通过单次手术实现长期肿瘤控制,包括43例接受辅助放疗者;多数肿瘤组织学良性,MIB-1指数低(<3.0%),少数主要为垂体特异性转录因子谱系的无症状腺瘤。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical treatment of giant pituitary adenomas is sometimes challenging. We present our surgical series of giant nonfunctioning adenomas to shed light on the limitations of effective and safe tumor resection. METHODS: The preoperative tumor characteristics, surgical approaches, outcome, and histology of giant nonfunctioning adenoma (>40 mm) in 128 consecutive surgical patients are reviewed. The follow-up period ranged from 19 to 113 months (mean 62.2 months). RESULTS: A transsphenoidal approach was used in the treatment of 109 patients and a combined transsphenoidal transcranial approach in 19 patients. A total of 93 patients (72.7%) underwent total resection or subtotal resection apart from the cavernous sinus (CS). The degree of tumor resection, excluding the marked CS invasion, was lower in tumors that were larger (P = 0.0107), showed massive intracranial extension (P = 0.0352), and had an irregular configuration (P = 0.0016). Permanent surgical complications developed in 28 patients (22.0%). Long-term tumor control was achieved in all patients by single surgery, including 43 patients with adjuvant radiotherapy. Most tumors were histologically benign, with a low MIB-1 index (<3.0%) beside a few tumors mainly silent adenomas of pituitary-specific transcription factor lineage. CONCLUSIONS: Irrespective of the surgical approach, massive intracranial extension, an irregular configuration, and marked CS invasion are inherent factors that independently limit effective resection. These high-risk tumors require an individualized therapeutic strategy.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Nishioka H, Hara T, Nagata Y, et al. Inherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas. World Neurosurg. 2017. PMID: 28735124. doi:10.1016/j.wneu.2017.07.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。